Aperio Management Team

Ali Radfar, M.D./MBA
Founder, CEO and CSO
Dr. Radfar is Founder, CEO and CSO of Aperio Beauty. His insightful vision for a novel way to target pre-mature aging began in 2015, when he realized genetics had not been introduced to the world of anti-aging. His pursuit of clinical excellence and agile strategic leadership has been the driving force behind bringing the Aperio serum to market.
Terry Rosenbaum
Co-Founder, CFO and COO
Terry Rosenbaum is Co-Founder, CFO and COO of Aperio Beauty. His collaborative operational rigor and expertise in analytics provide the basis for his creative insights and holistic view needed to lead finance and day to day operations.


Why I Began
Aperio Beauty

My experience in molecular genetics research has been a strong motivating influence towards the goal of creating a science-driven, genetics-focused anti-aging platform company, in the form of Aperio Beauty.

Prior to Aperio, Dr. Radfar was a Co-Founder and CEO of Neolitics, a revenue stage spectroscopy company offering analytic solutions across the chemical / petrochemical, food and beverage, and pharmaceutical sectors.

Prior to Neolitics, Dr. Radfar was a co-founder of the International Federation of Adipose Therapeutics and Science, a non-profit organization focused on adipose-derived stem cells, and their application towards tissue regeneration and therapeutics. He holds an M.D. from the University of Pittsburgh School of Medicine. During his medical school training, Ali spent 2 years working as a Molecular Genetics research associate, with a focus on applying novel gene therapy vehicles towards effecting scarless wound healing, in the context of both clinical medicine as well as aesthetics. It was through this experience, that he developed a keen appreciation of molecular genetics, as it may be applied towards the healing of skin and complex supporting skin structures. Dr. Radfar is also a Phi Beta Kappa honors graduate of the Johns Hopkins University, having earned a Bachelor of Arts degree in Molecular Cell Biology.

Dr. Radfar has also had more than 15 years of experience in healthcare finance including investment banking, equity research, consulting, and private equity. He has successfully completed more than $7.5 billion in transactions focused on company analytics in instrumentation, biotechnology, pharmaceutical, and medical device sectors. Dr. Radfar’s experience encompasses M&A transactions, IPOs, private placements, Private Investments in Public Equity (PIPE), registered direct offerings, and direct investment experience on behalf of buy-side firms and investor groups into targeted investments. He received an MBA from Duke University’s Fuqua School of Business, with concentrations in Corporate Finance and Strategy.

Contact Ali



    Getting personalized insights from understanding your DNA has always been an interest of mine.  I jumped at the opportunity to join Aperio Beauty and create a personalized beauty care regimen.

    Prior to Aperio Beauty, Terry has been a professional in the financial services industry for 5+ years, advising clients in the biopharma, life sciences, and diagnostics spaces, on strategic alternatives. He most recently worked at Perella Weinberg Partners as an Associate in their San Francisco office. His extensive experience includes:
    • Collaborating with management teams to effectively position their companies to potential buyers in multiple sale processes
    • Developing dynamic financial models to provide a holistic view to management of the value of their company
    • Presenting directly to management teams the pros and cons of various types of financing structures, their respective returns, and what their company’s financial profile will allow
    • Analyzing the economic impact of regional partnerships and the governance structures of the potential partnering transactions
    Terry holds a B.S. degree in Finance and Marketing from New York University’s Leonard N. Stern School of Business.

    Contact Terry

      Begin Your Journey Towards a Truly Personalized Serum